Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-19T02:45:52.839Z Has data issue: false hasContentIssue false

Epidemiological findings and medical, legal, and public health challenges of an investigation of severe soft tissue infections and deaths among injecting drug users – Ireland, 2000

Published online by Cambridge University Press:  29 November 2005

K. MURRAY-LILLIBRIDGE
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
J. BARRY
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
S. REAGAN
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
D. O'FLANAGAN
Affiliation:
National Disease Surveillance Centre, Dublin, Ireland
G. SAYERS
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
C. BERGIN
Affiliation:
St. James's Hospital, Dublin, Ireland
E. KEENAN
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
S. O'BRIAIN
Affiliation:
St. James's Hospital, Dublin, Ireland
P. PLUNKETT
Affiliation:
St. James's Hospital, Dublin, Ireland
G. McMAHON
Affiliation:
St. James's Hospital, Dublin, Ireland
C. KEANE
Affiliation:
St. James's Hospital, Dublin, Ireland
P. O'SULLIVAN
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
D. IGOE
Affiliation:
National Disease Surveillance Centre, Dublin, Ireland
L. MULLEN
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
M. WARD
Affiliation:
Eastern Regional Health Authority, Dublin, Ireland
A. SMITH
Affiliation:
National Disease Surveillance Centre, Dublin, Ireland
M. FISCHER
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In May 2000, public health authorities in Dublin, Ireland, identified a cluster of unexplained severe illness among injecting drug users (IDUs). Similar clusters were also reported in Scotland and England. Concurrent investigations were undertaken to identify the aetiology and source of the illnesses. In Dublin, 22 IDUs were identified with injection-site inflammation resulting in hospitalization or death; eight (36%) died. Common clinical findings among patients with severe systemic symptoms included leukaemoid reaction and cardiogenic shock. Seventeen (77%) patients reported injecting heroin intramuscularly in the 2 weeks before illness. Of 11 patients with adequate specimens available for testing, two (18%) were positive by 16S rDNA PCR for Clostridium novyi. Clinical and laboratory findings suggested that histotoxic Clostridia caused a subset of infections in these related clusters. Empiric treatment for infections among IDUs was optimized for anaerobic organisms, and outreach led to increased enrolment in methadone treatment in Dublin. Many unique legal, medical, and public health challenges were encountered during the investigation of this outbreak.

Type
Research Article
Copyright
2005 Cambridge University Press